More interestingly, recent AD genetics studies have demonstrated that an autosomal dominant AD PS1 E280A mutation carrier did not develop mild cognitive impairment (MCI) until her seventies, three decades after the expected age of clinically early AD onset. This evidence concerns the gene PSEN1 and Alzheimer disease.